Interaction of Mycophenolic Acid and Pantoprazole : A Pharmacokinetic Crossover Study
Intro -- Acknowledgements -- Summary -- Zusammenfassung -- List of Contents -- Figures -- Tables -- Abbreviations -- 1 Introduction -- 1.1 Mycophenolic Acid -- 1.1.1 Chemical Properties -- 1.2 Pharmacology of MPA -- 1.2.1 Pharmacokinetics of MPA -- 1.2.2 Pharmacokinetic Interactions of MPA -- 1.2.3 Clinical Aspects of MPA Pharmacokinetics -- 1.2.4 Pharmacodynamics of MPA -- 1.3 Analytical Aspects of MPA Measurement and Its Metabolites -- 1.3.1 Sample Preparation -- 1.3.2 Chromatography -- 1.3.3 Stability -- 1.3.4 Assays for Determination of MPA and Its Metabolites -- 1.4 Pharmacology of Pantoprazole -- 2 Research Objectives -- 3 Materials -- 3.1 Chemicals -- 3.2 Kits -- 3.3 Consumable Material -- 3.4 Hardware and Software -- 3.4.1 Hardware -- 3.4.2 Software -- 4 Methods -- 4.1 Quantification of MPA and MPAG in Human Plasma -- 4.1.1 Sample Preparation -- 4.2 Measurement of IMPDH Activity -- 4.3 Validation Conditions -- 4.3.1 Preparation of Calibration and Quality Control Standards -- 4.3.2 Selectivity -- 4.3.3 Limit of Detection -- 4.3.4 LLOQ -- 4.3.5 Linearity -- 4.3.6 Bias and Precision -- 4.3.7 Carry-Over -- 4.3.8 Dilution Integrity -- 4.3.9 Extraction Recovery -- 4.3.10 Method Comparison -- 4.3.11 Stability -- 4.4 PK/PD Study about an Interaction of Pantoprazole and Mycophenolic Acid -- 4.4.1 Study Description -- 4.4.2 Inclusion and Exclusion Criteria -- 4.4.3 Sample Pre-Treatment and Laboratory Analysis -- 4.4.4 Pharmacokinetic and Pharmacodynamic Analysis -- 4.4.5 Data Evaluation and Statistical Analysis -- 4.4.6 Sample Size Calculations -- 4.4.7 Descriptive Analysis -- 5 Results -- 5.1 Validation of an HPLC-UV Assay for Quantification of MPA and MPAG in Human Plasma -- 5.1.1 Limit of Detection -- 5.1.2 Selectivity -- 5.1.3 Linearity -- 5.1.4 Accuracy -- 5.1.5 Carry-Over -- 5.1.6 Dilution Integrity -- 5.1.7 Extraction Recovery.
5.1.8 Method Comparison -- 5.1.9 Stability -- 5.2 PK/PD Study about an Interaction of Pantoprazole and Mycophenolic Acid -- 5.2.1 Analytical Aspects of Study Samples Measurement -- 5.2.2 Statistical Considerations for Sample Size Calculation -- 5.2.3 Demographics -- 5.2.4 Adverse Events -- 5.2.5 Pharmacokinetics of MPA -- 5.2.6 Pharmacokinetics of MPAG -- 5.2.7 Pharmacodynamics of MPA -- 6 Discussion -- 6.1 Quantification of MPA and MPAG in Human Plasma -- not -- 6.1.1 Sample Preparation -- 6.1.2 Chromatographic Conditions -- 6.1.3 Validation Parameters -- 6.1.4 Method Comparison -- 6.1.5 Stability -- 6.1.6 Conclusion and Final Remarks -- 6.2 PK/PD Study about an Interaction of Pantoprazole and Mycophenolic Acid -- 6.2.1 Pharmacokinetics of MPA after EC-MPS and MMF Intake -- 6.2.2 Influence of Pantoprazole on MPA Pharmacokinetics -- 6.2.3 Influence of Pantoprazole on MPAG Pharmacokinetics -- 6.2.4 Influence of Pantoprazole on IMPDH Activity -- 6.2.5 Proton Pump Inhibitors and Their Clinical Role in MPA Treatment -- 6.2.6 Limitations of the PK/PD Study -- 6.2.7 Conclusion and Final Remarks -- 7 References -- 8 Appendix -- 8.1 Short-Term Stability Analysis of Unprocessed Lithium-Heparin Blood at Room Temperature -- 8.2 Demographics of All Patients in the PK/PD Study to Investigate the Interaction of Pantoprazole and MPA -- 8.3 LMEM Results of the PK/PD Study on the Interaction of Pantoprazole and Mycophenolic Acid -- 8.3.1 LMEM Syntax for Evaluation of MPA, MPAG Pharmacokinetics and MPA Pharmacodynamics -- 8.3.2 LMEM Output of MPA Pharmacokinetics after MPA±PAN Intake -- 8.3.3 LMEM Output of MPAG pharmacokinetics after MPA±PAN Intake -- 8.3.4 LMEM Output of MPA Pharmacodynamics after MPA±PAN Intake.
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
Wiesbaden: Spektrum Akademischer Verlag ; 2017 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rissling, Olesja [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
ISBN: |
---|
Themen: |
Drug interactions |
---|
Umfang: |
1 Online-Ressource (177 pages) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
1046140493 |
---|
LEADER | 01000cam a22002652 4500 | ||
---|---|---|---|
001 | 1046140493 | ||
003 | DE-627 | ||
005 | 20230427060830.0 | ||
007 | cr uuu---uuuuu | ||
008 | 190111s2017 xx |||||o 00| ||eng c | ||
020 | |a 9783658198893 |c : electronic bk. |9 978-3-658-19889-3 | ||
020 | |z 9783658198886 | ||
035 | |a (DE-627)1046140493 | ||
035 | |a (DE-599)GBV1046140493 | ||
035 | |a (EBC)EBC5122212 | ||
035 | |a (EBR)ebr11467043 | ||
035 | |a (EBL)EBL5122212 | ||
035 | |a (EBP)03652669X | ||
040 | |a DE-627 |b eng |c DE-627 |e rda | ||
041 | |a eng | ||
050 | 0 | |a RM1-950R108 | |
082 | 0 | |a 615.37 23 | |
100 | 1 | |a Rissling, Olesja |e verfasserin |4 aut | |
245 | 1 | 0 | |a Interaction of Mycophenolic Acid and Pantoprazole |b A Pharmacokinetic Crossover Study |
264 | 1 | |a Wiesbaden |b Spektrum Akademischer Verlag |c 2017 | |
300 | |a 1 Online-Ressource (177 pages) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Intro -- Acknowledgements -- Summary -- Zusammenfassung -- List of Contents -- Figures -- Tables -- Abbreviations -- 1 Introduction -- 1.1 Mycophenolic Acid -- 1.1.1 Chemical Properties -- 1.2 Pharmacology of MPA -- 1.2.1 Pharmacokinetics of MPA -- 1.2.2 Pharmacokinetic Interactions of MPA -- 1.2.3 Clinical Aspects of MPA Pharmacokinetics -- 1.2.4 Pharmacodynamics of MPA -- 1.3 Analytical Aspects of MPA Measurement and Its Metabolites -- 1.3.1 Sample Preparation -- 1.3.2 Chromatography -- 1.3.3 Stability -- 1.3.4 Assays for Determination of MPA and Its Metabolites -- 1.4 Pharmacology of Pantoprazole -- 2 Research Objectives -- 3 Materials -- 3.1 Chemicals -- 3.2 Kits -- 3.3 Consumable Material -- 3.4 Hardware and Software -- 3.4.1 Hardware -- 3.4.2 Software -- 4 Methods -- 4.1 Quantification of MPA and MPAG in Human Plasma -- 4.1.1 Sample Preparation -- 4.2 Measurement of IMPDH Activity -- 4.3 Validation Conditions -- 4.3.1 Preparation of Calibration and Quality Control Standards -- 4.3.2 Selectivity -- 4.3.3 Limit of Detection -- 4.3.4 LLOQ -- 4.3.5 Linearity -- 4.3.6 Bias and Precision -- 4.3.7 Carry-Over -- 4.3.8 Dilution Integrity -- 4.3.9 Extraction Recovery -- 4.3.10 Method Comparison -- 4.3.11 Stability -- 4.4 PK/PD Study about an Interaction of Pantoprazole and Mycophenolic Acid -- 4.4.1 Study Description -- 4.4.2 Inclusion and Exclusion Criteria -- 4.4.3 Sample Pre-Treatment and Laboratory Analysis -- 4.4.4 Pharmacokinetic and Pharmacodynamic Analysis -- 4.4.5 Data Evaluation and Statistical Analysis -- 4.4.6 Sample Size Calculations -- 4.4.7 Descriptive Analysis -- 5 Results -- 5.1 Validation of an HPLC-UV Assay for Quantification of MPA and MPAG in Human Plasma -- 5.1.1 Limit of Detection -- 5.1.2 Selectivity -- 5.1.3 Linearity -- 5.1.4 Accuracy -- 5.1.5 Carry-Over -- 5.1.6 Dilution Integrity -- 5.1.7 Extraction Recovery | ||
520 | |a 5.1.8 Method Comparison -- 5.1.9 Stability -- 5.2 PK/PD Study about an Interaction of Pantoprazole and Mycophenolic Acid -- 5.2.1 Analytical Aspects of Study Samples Measurement -- 5.2.2 Statistical Considerations for Sample Size Calculation -- 5.2.3 Demographics -- 5.2.4 Adverse Events -- 5.2.5 Pharmacokinetics of MPA -- 5.2.6 Pharmacokinetics of MPAG -- 5.2.7 Pharmacodynamics of MPA -- 6 Discussion -- 6.1 Quantification of MPA and MPAG in Human Plasma -- not -- 6.1.1 Sample Preparation -- 6.1.2 Chromatographic Conditions -- 6.1.3 Validation Parameters -- 6.1.4 Method Comparison -- 6.1.5 Stability -- 6.1.6 Conclusion and Final Remarks -- 6.2 PK/PD Study about an Interaction of Pantoprazole and Mycophenolic Acid -- 6.2.1 Pharmacokinetics of MPA after EC-MPS and MMF Intake -- 6.2.2 Influence of Pantoprazole on MPA Pharmacokinetics -- 6.2.3 Influence of Pantoprazole on MPAG Pharmacokinetics -- 6.2.4 Influence of Pantoprazole on IMPDH Activity -- 6.2.5 Proton Pump Inhibitors and Their Clinical Role in MPA Treatment -- 6.2.6 Limitations of the PK/PD Study -- 6.2.7 Conclusion and Final Remarks -- 7 References -- 8 Appendix -- 8.1 Short-Term Stability Analysis of Unprocessed Lithium-Heparin Blood at Room Temperature -- 8.2 Demographics of All Patients in the PK/PD Study to Investigate the Interaction of Pantoprazole and MPA -- 8.3 LMEM Results of the PK/PD Study on the Interaction of Pantoprazole and Mycophenolic Acid -- 8.3.1 LMEM Syntax for Evaluation of MPA, MPAG Pharmacokinetics and MPA Pharmacodynamics -- 8.3.2 LMEM Output of MPA Pharmacokinetics after MPA±PAN Intake -- 8.3.3 LMEM Output of MPAG pharmacokinetics after MPA±PAN Intake -- 8.3.4 LMEM Output of MPA Pharmacodynamics after MPA±PAN Intake | ||
650 | 0 | |a Drug interactions | |
650 | 0 | |a Mycophenolic acid | |
650 | 4 | |a Mycophenolic acid.. | |
650 | 4 | |a Drug interactions | |
650 | 4 | |a Electronic books | |
776 | 1 | |z 9783658198886 | |
776 | 0 | 8 | |i Print version |a Rissling, Olesja |t Interaction of Mycophenolic Acid and Pantoprazole : A Pharmacokinetic Crossover Study |d Wiesbaden : Spektrum Akademischer Verlag,c2017 |z 9783658198886 |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=5122212 |m X:EBC |x Aggregator |z lizenzpflichtig |3 Volltext |
912 | |a ZDB-30-PQE | ||
912 | |a GBV_ILN_206 | ||
912 | |a ISIL_DE-Brg3 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_736 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a ISIL_DE-289 | ||
951 | |a BO | ||
953 | |2 045F |a 615.37 23 | ||
980 | |2 206 |1 01 |x 3350 |b 1842709305 |c 00 |f --%%-- |d Online-Ressource |e g |j --%%-- |h OLR-EBL |k If you are a ThHF affiliate and the E-Book is not fully accessible, please send us a purchase or short time loan request. All others: Inter-library loans and guest access on campus premises is not possible. |y zh |z 23-01-19 | ||
980 | |2 736 |1 01 |x 4736 |b 4498907000 |h EBC-Content |y zeg |z 08-03-24 | ||
980 | |2 2021 |1 01 |x DE-289 |b 3844893520 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 29-01-21 | ||
981 | |2 206 |1 01 |x 3350 |y Full Text only for ThHF affiliates |r https://thh-friedensau.idm.oclc.org/login?url=http://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=5122212 | ||
981 | |2 736 |1 01 |x 4736 |r https://ebookcentral.proquest.com/lib/staat/detail.action?docID=5122212 | ||
981 | |2 2021 |1 01 |x DE-289 |r https://ebookcentral.proquest.com/lib/kiz-uniulm/detail.action?docID=5122212 | ||
995 | |2 206 |1 01 |x 3350 |a OLR-EBL | ||
995 | |2 736 |1 01 |x 4736 |a EBC-Content |